AI assistant
Sending…
RESMED INC — Director's Dealing 2022
Nov 29, 2022
30071_dirs_2022-11-29_ab7ab63c-dc66-475b-b960-a2a3f21edc67.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2022-11-25
Reporting Person: PENDARVIS DAVID (Chief Administrative Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-11-25 | ResMed Common Stock | M | 683 | $146.34 | Acquired | 107472 | Direct |
| 2022-11-28 | ResMed Common Stock | G | 7300 | — | Disposed | 100172 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-11-25 | ResMed Common Stock Options | $146.34 | M | 683 | Disposed | 2026-11-21 | ResMed Common Stock (683) | Direct |
Footnotes
F1: Gift of shares to The San Diego Foundation, a 501(c)(3) nonprofit organization. Mr. Pendarvis has no beneficial interest, control or dispositive power over the gifted shares.
F2: Represents date options first became exercisable. Options vest 1/3 per year.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29